Market Tracker

04/28 5:16pm ET

Meridian Bioscience Inc (NASDAQ:VIVO)

14.80
Delayed Data
As of Apr 28
 -0.20 / -1.33%
Today’s Change
10.75
Today|||52-Week Range
21.49
-16.38%
Year-to-Date
VIVO Regular Dividend: VIVO will begin trading ex-dividend on 05/04/17 with a $0.125 dividend payable to shareholders of record as of 05/08/17.
No recent news for Meridian Bioscience Inc.

Today’s Trading

Previous close15.00
Today’s open15.20
Day’s range14.70 - 15.20
Volume434,713
Average volume (3 months)406,572
Market cap$624.6M
Dividend yield3.38%
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-10.59%
Earnings growth (this year)-15.36%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+0.64%
P/E ratio21.1
Price/Sales4.17
Price/Book3.74

Competitors

 Today’s
change
Today’s
% change
IMMUImmunomedics Inc+0.13+2.32%
ALRPRBAlere Inc+3.24+0.85%
--Quidel Corp+0.29+1.35%
LNTHLantheus Holdings In...+0.15+1.17%
Data as of 4:00pm ET, 04/28/2017

Financials

Last reporting dateApril 27, 2017
EPS forecast (this quarter)$0.19
Annual revenue (last year)$196.1M
Annual profit (last year)$32.2M
Net profit margin16.44%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John A. Kraeutler
President &
Chief Commercial Officer
Richard L. Eberly
Corporate headquarters
Cincinnati, Ohio

Forecasts